NASDAQ

Actuate Therapeutics, Inc. (ACTU)

♥ 579 Thanks from members

Live price chart, market sentiment, and community perspectives for Actuate Therapeutics, Inc. (NASDAQ: ACTU).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Actuate Therapeutics ManagementLeadership: Daniel Schmitt (CEO)Leadership: Dr. Mark Pykett (President)Holder: BioCrossroadsHolder: Life Sciences InvestorsHolder: Venture FundsElraglusib (9-ING-41)GSK-3beta Inhibitors#ACTU#Actuate Therapeutics#Biotech Stock#Oncology Drugs#Elraglusib